{"Abstract": "The field of adult transgender medicine has seen significant advancements, particularly in the realm of gender-affirming hormone treatment (GAHT), as outlined in the Endocrine Society's 2017 treatment guidelines. This update focuses on the latest evidence-based practices for the care of transgender individuals, including transfeminine and transmasculine patients. It highlights the importance of personalized treatment plans, the monitoring of hormone therapy effects, and the management of potential risks associated with GAHT. The guidelines emphasize a multidisciplinary approach to care, incorporating endocrinological, psychological, and surgical perspectives to support the health and well-being of transgender adults. This abstract aims to provide a concise overview of current recommendations and considerations in adult transgender medicine, reflecting the evolving understanding and treatment of gender dysphoria."}